Cargando…

Chimeric Bivalent Virus-Like Particle Vaccine for H5N1 HPAI and ND Confers Protection against a Lethal Challenge in Chickens and Allows a Strategy of Differentiating Infected from Vaccinated Animals (DIVA)

Highly pathogenic avian influenza (HPAI) and Newcastle disease (ND) are considered as the most devastating poultry infections, owing to their worldwide distribution and economical threat. Vaccines have been widely used to control these diseases in the poultry industry in endemic countries. However,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Noh, Jin-Yong, Park, Jae-Keun, Lee, Dong-Hun, Yuk, Seong-Su, Kwon, Jung-Hoon, Lee, Sang-Won, Lee, Joong-Bok, Park, Seung-Yong, Choi, In-Soo, Song, Chang-Seon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5023191/ https://www.ncbi.nlm.nih.gov/pubmed/27626934 http://dx.doi.org/10.1371/journal.pone.0162946

Ejemplares similares

Protective efficacy of crude virus‐like particle vaccine against HPAI H5N1 in chickens and its application on DIVA strategy
por: Park, Jae‐Keun, et al.
Publicado: (2012)

Efficacy of Single Dose of a Bivalent Vaccine Containing Inactivated Newcastle Disease Virus and Reassortant Highly Pathogenic Avian Influenza H5N1 Virus against Lethal HPAI and NDV Infection in Chickens
por: Lee, Dong-Hun, et al.
Publicado: (2013)

Aujeszky’s Disease and the Development of the Marker/DIVA Vaccination Concept
por: Mettenleiter, Thomas C.
Publicado: (2020)

Live Recombinant NDV-Vectored H5 Vaccine Protects Chickens and Domestic Ducks From Lethal Infection of the Highly Pathogenic H5N6 Avian Influenza Virus
por: Lee, Jiho, et al.
Publicado: (2022)

Diva
por: Matheopoulos, Helena
Publicado: (1993)

Comparative Effectiveness of COVID-19 Bivalent Versus Monovalent mRNA Vaccines in the Early Stage of Bivalent Vaccination in Korea: October 2022 to January 2023
por: Kim, Ryu Kyung, et al.
Publicado: (2023)

Scoring and psychometric validation of the ‘Determinants of Intentions to Vaccinate’ (DIVA(©)) questionnaire
por: Martinez, Luc, et al.
Publicado: (2016)

Development of an Inactivated H7N9 Subtype Avian Influenza Serological DIVA Vaccine Using the Chimeric HA Epitope Approach
por: Sun, Zhihao, et al.
Publicado: (2021)

Las divas
por: Torres, Juan Manuel
Publicado: (1962)

Production of a chimeric porcine reproductive and respiratory syndrome virus (PRRSV)-2 vaccine using a lab-scale packed-bed bioreactor CelCradle
por: Choi, Hwi-Yeon, et al.
Publicado: (2023)

Exchange of C-Terminal Variable Sequences within Morbillivirus Nucleocapsid Protein Are Tolerated: Development and Evaluation of Two Marker (DIVA) Vaccines (Sungri/96 DIVA, Nigeria/75/1 DIVA) against PPR
por: Selvaraj, Muneeswaran, et al.
Publicado: (2021)

Erratum to: Scoring and psychometric validation of the ‘Determinants of Intentions to Vaccinate’ (DIVA(©)) questionnaire
por: Martinez, Luc, et al.
Publicado: (2016)

Correction: Production of a chimeric porcine reproductive and respiratory syndrome virus (PRRSV)-2 vaccine using a lab-scale packed-bed bioreactor CelCradle
por: Choi, Hwi-Yeon, et al.
Publicado: (2023)

A review of vaccine development and research for industry animals in Korea
por: Lee, Nak-Hyung, et al.
Publicado: (2012)

Salmonella DIVA vaccine reduces disease, colonization and shedding due to virulent S. Typhimurium infection in swine
por: Bearson, Bradley L, et al.
Publicado: (2017)

Immunogenicity of a bivalent killed thimerosal-free oral cholera vaccine, Euvichol, in an animal model
por: Lee, Eun Young, et al.
Publicado: (2018)

Proteomic and immunoproteomic characterization of a DIVA subunit vaccine against Actinobacillus pleuropneumoniae
por: Buettner, Falk FR, et al.
Publicado: (2011)

Development of a chimeric strain of porcine reproductive and respiratory syndrome virus with an infectious clone and a Korean dominant field strain
por: Lee, Jung-Ah, et al.
Publicado: (2014)

Development of porcine respiratory and reproductive syndrome virus replicon vector for foot-and-mouth disease vaccine
por: Jeeva, Subbiah, et al.
Publicado: (2014)

Development of a novel vaccine against canine parvovirus infection with a clinical isolate of the type 2b strain
por: Park, Seon Ah, et al.
Publicado: (2012)

Novel Foot-and-Mouth Disease Vaccine Platform: Formulations for Safe and DIVA-Compatible FMD Vaccines With Improved Potency
por: Hardham, John M., et al.
Publicado: (2020)

DIVA metabolomics: Differentiating vaccination status following viral challenge using metabolomic profiles
por: Gray, Darren W., et al.
Publicado: (2018)

Assessing the Protective Dose of a Candidate DIVA Vaccine against Classical Swine Fever
por: Jelsma, Tinka, et al.
Publicado: (2021)

Scale-Up Production of Type O and A Foot-and-Mouth Disease Bivalent Vaccine and Its Protective Efficacy in Pigs
por: Park, Sang-Hyun, et al.
Publicado: (2021)

Pre-immune state induced by chicken interferon gamma inhibits the replication of H1N1 human and H9N2 avian influenza viruses in chicken embryo fibroblasts
por: Yuk, Seong-Su, et al.
Publicado: (2016)

Lineage‐specific epitope profiles for HPAI H5 pre‐pandemic vaccine selection and evaluation
por: Qiu, Xueting, et al.
Publicado: (2017)

Comparison between dot-immunoblotting assay and clinical sign determination method for quantifying avian infectious bronchitis virus vaccine by titration in embryonated eggs
por: Yuk, Seong-su, et al.
Publicado: (2016)

Immuno-profiling of Brucella proteins for developing improved vaccines and DIVA capable serodiagnostic assays for brucellosis
por: Nandini, Prachita, et al.
Publicado: (2023)

A Single Vaccination of Chimeric Bivalent Virus-Like Particle Vaccine Confers Protection Against H9N2 and H3N2 Avian Influenza in Commercial Broilers and Allows a Strategy of Differentiating Infected from Vaccinated Animals
por: Sun, Yi-xue, et al.
Publicado: (2022)

Development of a Chimeric Porcine Reproductive and Respiratory Syndrome Virus (PRRSV)-2 Vaccine Candidate Expressing Hypo-Glycosylated Glycoprotein-5 Ectodomain of Korean Lineage-1 Strain
por: Choi, Hwi-Yeon, et al.
Publicado: (2022)

Safety, Protective Immunity, and DIVA Capability of a Rough Mutant Salmonella Pullorum Vaccine Candidate in Broilers
por: Guo, Rongxian, et al.
Publicado: (2017)

Development of Differentiating Infected from Vaccinated Animals (DIVA) Real-Time PCR for African Horse Sickness Virus Serotype 1
por: Wang, Yifan, et al.
Publicado: (2022)

Antibody Quality and Protection from Lethal Ebola Virus Challenge in Nonhuman Primates Immunized with Rabies Virus Based Bivalent Vaccine
por: Blaney, Joseph E., et al.
Publicado: (2013)

A novel bivalent Pasteurellosis-RHD vaccine candidate adjuvanted with Montanide ISA70 protects rabbits from lethal challenge
por: El-Jakee, Jakeen K., et al.
Publicado: (2020)

Newcastle disease virus vectored vaccines as bivalent or antigen delivery vaccines
por: Choi, Kang-Seuk
Publicado: (2017)

Effect of a DIVA vaccine with and without in-feed use of coated calcium-butyrate on transmission of Salmonella Typhimurium in pigs
por: De Ridder, Lotte, et al.
Publicado: (2013)

Efficacy of bacteriophage Lysed Pasteurella marker vaccine in laboratory animal models with a novel DIVA for haemorrhagic septicaemia
por: Qureshi, Sabia, et al.
Publicado: (2019)

A Bivalent Inactivated Vaccine Prevents Enterovirus 71 and Coxsackievirus A16 Infections in the Mongolian Gerbil
por: Yi, Eun-Je, et al.
Publicado: (2023)

Complete Genome Sequence of a Natural Recombinant H9N2 Influenza Virus from Wild Birds in Republic of Korea
por: Lee, Dong-Hun, et al.
Publicado: (2013)

Complete Genome Sequence of a Natural Recombinant H9N2 Influenza Virus Isolated from a White-Fronted Goose (Anser albifrons) in South Korea
por: Lee, Dong-Hun, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_nbmdpseebfch2rbak2onvknb9c